Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Cleaver, James
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing.
Synchronous Presentation of a Cervical Spinal Schwannoma and Primary Progressive Multiple Sclerosis in a 65-year-old Man.
Transfusion Makeovers by Thromboelastometry-Does It Work for Everyone?
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing.
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol. 2006 Oct 15; 177(8):5088-97.
View in:
PubMed
subject areas
Antigen Presentation
Antigens, Neoplasm
Cell Line, Tumor
Histocompatibility Antigens Class I
Humans
Interferon-gamma
Neoplasms
Peptides
Receptor, ErbB-2
T-Lymphocytes, Cytotoxic
Tumor Necrosis Factor-alpha
authors with profiles
William H Hildebrand